957187-37-0 Usage
General Description
The chemical "(R)-2-(6-(tert-butoxycarbonyl)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl)acetic acid" is a compound with a complex molecular structure. It contains a spiro ring system and a carboxylic acid functional group. The presence of the tert-butoxycarbonyl (Boc) protecting group suggests that this compound may be used in the synthesis of other organic molecules. The 3,5-difluorophenyl group indicates that this compound contains a phenyl ring with fluorine substituents at the 3 and 5 positions. The presence of the acetic acid moiety suggests that this compound may have acidic properties and could be involved in chemical reactions as an acid or a leaving group. Overall, this compound is likely to be a versatile building block for the synthesis of other organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 957187-37-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,7,1,8 and 7 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 957187-37:
(8*9)+(7*5)+(6*7)+(5*1)+(4*8)+(3*7)+(2*3)+(1*7)=220
220 % 10 = 0
So 957187-37-0 is a valid CAS Registry Number.
957187-37-0Relevant articles and documents
Discovery of MK-3207: A highly potent, orally bioavailable CGRP receptor antagonist
Bell, Ian M.,Gallicchio, Steven N.,Wood, Michael R.,Quigley, Amy G.,Stump, Craig A.,Zartman, C. Blair,Fay, John F.,Li, Chi-Chung,Lynch, Joseph J.,Moore, Eric L.,Mosser, Scott D.,Prueksaritanont, Thomayant,Regan, Christopher P.,Roller, Shane,Salvatore, Christopher A.,Kane, Stefanie A.,Vacca, Joseph P.,Selnick, Harold G.
scheme or table, p. 24 - 29 (2010/11/04)
Incorporation of polar functionality into a series of highly potent calcitonin gene-related peptide (CGRP) receptor antagonists was explored in an effort to improve pharmacokinetics. This strategy identified piperazinone analogues that possessed improved
